BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19034773)

  • 1. Rituximab-induced severe acute thrombocytopenia: a case report and review of literature.
    Dhand S; Bahrain H
    Cancer Invest; 2008 Nov; 26(9):913-5. PubMed ID: 19034773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab-associated acute thrombocytopenia: an under-diagnosed phenomenon.
    Ram R; Bonstein L; Gafter-Gvili A; Ben-Bassat I; Shpilberg O; Raanani P
    Am J Hematol; 2009 Apr; 84(4):247-50. PubMed ID: 19260124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab-induced acute thrombocytopenia: a report of two cases.
    Otrock ZK; Mahfouz RA; Oghlakian GO; Salem ZM; Bazarbachi A
    Haematologica; 2005 Nov; 90 Suppl():ECR23. PubMed ID: 16266914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum sickness following treatment with rituximab.
    Todd DJ; Helfgott SM
    J Rheumatol; 2007 Feb; 34(2):430-3. PubMed ID: 17295433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab-induced acute severe thrombocytopenia.
    Parajuli R; Hire E; Shah BK
    Br J Haematol; 2010 Jun; 149(6):804. PubMed ID: 20602622
    [No Abstract]   [Full Text] [Related]  

  • 6. Remarkable response to rituximab in a patient with atypical CD20(++) mantle cell lymphoma of the bone marrow leading to severe pancytopenia.
    Seggewiss R; Ho AD; Kraemer A
    Ann Hematol; 2004 May; 83(5):316-8. PubMed ID: 15064861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of B lymphocytes from cerebral perivascular spaces by rituximab.
    Martin Mdel P; Cravens PD; Winger R; Kieseier BC; Cepok S; Eagar TN; Zamvil SS; Weber MS; Frohman EM; Kleinschmidt-Demasters BK; Montine TJ; Hemmer B; Marra CM; Stüve O
    Arch Neurol; 2009 Aug; 66(8):1016-20. PubMed ID: 19667224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular tachycardia associated with infusion of rituximab in mantle cell lymphoma.
    Arai Y; Tadokoro J; Mitani K
    Am J Hematol; 2005 Apr; 78(4):317-8. PubMed ID: 15795913
    [No Abstract]   [Full Text] [Related]  

  • 9. Rituximab-induced acute severe thrombocytopenia: a case series in patients with mantle cell lymphoma.
    Sadashiv SK; Rao R; Fazal S; Lister J
    Clin Lymphoma Myeloma Leuk; 2013 Oct; 13(5):602-5. PubMed ID: 23870855
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe thrombocytopenia and fibrinolysis mimicking disseminated intravascular coagulation after rituximab infusion.
    Kotsianidis I; Goutzouvelidis A; Anastasiades A; Bouchliou I; Nakou E; Spanoudakis E; Christophoridou AV; Margaritis D; Bourikas G; Tsatalas C
    Am J Hematol; 2010 Feb; 85(2):146. PubMed ID: 20052746
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe hematological side effects following Rituximab therapy in children.
    Larrar S; Guitton C; Willems M; Bader-Meunier B
    Haematologica; 2006 Aug; 91(8 Suppl):ECR36. PubMed ID: 16923520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab-induced acute thrombocytopenia: a case report and review of the literature.
    Yi JH; Kim SJ; Ahn HK; Lee SJ; Chang MH; Kim WS
    Med Oncol; 2009; 26(1):45-8. PubMed ID: 18543133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment.
    Quartier P; Tournilhac O; Archimbaud C; Lazaro L; Chaleteix C; Millet P; Peigue-Lafeuille H; Blanche S; Fischer A; Casanova JL; Travade P; Tardieu M
    Clin Infect Dis; 2003 Feb; 36(3):e47-9. PubMed ID: 12539090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchiolitis obliterans with organizing pneumonia after rituximab therapy for non-Hodgkin's lymphoma.
    Biehn SE; Kirk D; Rivera MP; Martinez AE; Khandani AH; Orlowski RZ
    Hematol Oncol; 2006 Dec; 24(4):234-7. PubMed ID: 16948177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case report of rituximab-induced thrombocytopenia.
    Shah C; Grethlein SJ
    Am J Hematol; 2004 Apr; 75(4):263. PubMed ID: 15054827
    [No Abstract]   [Full Text] [Related]  

  • 16. Late-onset neutropenia following viral bone marrow depression after rituximab therapy.
    Christopeit M; Haak U; Behre G
    Ann Hematol; 2008 Sep; 87(9):761-2. PubMed ID: 18350295
    [No Abstract]   [Full Text] [Related]  

  • 17. Intraperitoneal application of rituximab in refractory mantle cell lymphoma with massive ascites resulting in local and systemic response.
    Crysandt M; Neumann B; Das M; Engelbertz V; Bendel M; Galm O; Osieka R; Jost E
    Eur J Haematol; 2007 Dec; 79(6):546-9. PubMed ID: 17903214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe acute thrombocytopenia following rituximab therapy.
    Rosado M; Chao H; Rose M
    Leuk Lymphoma; 2007 Nov; 48(11):2239-40. PubMed ID: 17926181
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapid infusion rituximab changing practice for patient care.
    Al Zahrani A; Ibrahim N; Al Eid A
    J Oncol Pharm Pract; 2009 Sep; 15(3):183-6. PubMed ID: 19171551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstitial pneumonitis related to rituximab therapy.
    Burton C; Kaczmarski R; Jan-Mohamed R
    N Engl J Med; 2003 Jun; 348(26):2690-1; discussion 2690-1. PubMed ID: 12826649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.